Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Patient Response Trajectories in Major Depressive Disorder
1
x
$
30.00
Letter From the Editors: Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
1
x
$
0.00
VOL 47 No. 3 Table of Contents
1
x
$
0.00
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
1
x
$
30.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
1
x
$
0.00
Diagnosis and Staging of Gynecological Malignancies
1
x
$
0.00
Psychopharmacology Bulletin VOL 46 No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Pharmacy Practice: In Vitro Tests to Predict Human Tumor Sensitivity to Cytotoxic Agents
1
x
$
0.00
Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?
1
x
$
0.00
View Cart
Checkout
Home
Store
“Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Can We Distinguish Anxiety From Depression?
$
30.00
Add to cart
Details
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
$
30.00
Add to cart
Details
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
Gender-Specific Differences in Depression and Treatment Response
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Treatment of Panic Disorder: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
